Docs Recruit Women For Breast Cancer Study
|
 |
Also on the Web |
|
|
|
|
|
|
|
Pictures are a bittersweet way for Anne Dery to reunite with her mom. But it was her mom's tragic death that has helped Anne stay focused on her goals - to help protect others from watching a loved one die of breast cancer, and to protect herself.
"I do monthly self breast exams and have a yearly mammogram," says Anne.
Anne also enrolled in a groundbreaking study called the STAR trial. Dr. Sandhya Pruthi says the study will determine which of these two drugs, Tamoxifen or Relaxifene, is most effective at preventing breast cancer in high risk women.
"Both are anti-estrogens, which is ideal for protecting your breast from exposure to estrogen. They're estrogen blockers."
Long-term exposure to estrogen, especially after menopause, may increase your risk of breast cancer. Why? Because estrogen may cause breast tissue cells to multiply, eventually forming tumor and blocking those cells with anti-estrogen medications cuts your risk of developing the disease, a disease that took a dear mother away from Anne.
|
